Daan van Overveld

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Janssen (Netherlands)(Current)

Corbion (Netherlands)

Janssen (United States)

Daan van Overveld is an author at Janssen (Netherlands) specializing in vaccine candidate screening, molecular biology, and vaccine antigen discovery.

ORCID

Publications per year

2024–2024

Publications

Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer

Mark J. G. Bakkers, Tina Ritschel, Machteld M. Tiemessen et al. · Nature Communications · 2024 · 34 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses

Mark J. G. Bakkers, Freek Cox, Annemart Koornneef et al. · Nature Microbiology · 2024 · 23 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein

Johannes P. M. Langedijk, Freek Cox, Nicole V. Johnson et al. · Nature Communications · 2024 · 14 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G

Richard Voorzaat, Freek Cox, Daan van Overveld et al. · Vaccines · 2024 · 13 citations · Full text

Veterinary Medicine, Biotechnology, Infectious Diseases +17

1–4 of 4